Ticagrelor in Comparison to Prasugrel for Early Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)
Conditions
Interventions
- DRUG: Prasugrel
- DRUG: Ticagrelor
Sponsor
University of Patras